메뉴 건너뛰기




Volumn 42, Issue 3, 2014, Pages 235-237

18F-FDG PET and PET/CT in diagnosis and treatment monitoring of pyrexia of unknown origin due to tuberculosis with prominent hepatosplenic involvement

Author keywords

18F FDG PET CT; Infectious disease; Pyrexia of unknown origin; Second line antitubercular therapy; Tuberculosis

Indexed keywords

CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; FLUORODEOXYGLUCOSE F 18; ISONIAZID; KANAMYCIN; LEVOFLOXACIN; PYRAZINAMIDE; RIFAMPICIN; RADIOPHARMACEUTICAL AGENT; TUBERCULOSTATIC AGENT;

EID: 84906963979     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnmt.113.132985     Document Type: Article
Times cited : (8)

References (4)
  • 2
    • 56349168880 scopus 로고    scopus 로고
    • Positron emission tomography as a diagnostic tool in infection: present role and future possibilities
    • Basu S, Chryssikos T, Moghadam-Kia S, Zhuang H, Torigian DA, Alavi A. Positron emission tomography as a diagnostic tool in infection: present role and future possibilities. Semin Nucl Med. 2009;39:36-51.
    • (2009) Semin Nucl Med. , vol.39 , pp. 36-51
    • Basu, S.1    Chryssikos, T.2    Moghadam-Kia, S.3    Zhuang, H.4    Torigian, D.A.5    Alavi, A.6
  • 4
    • 70349733410 scopus 로고    scopus 로고
    • Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDGPET
    • Basu S, Asopa RV, Baghel NS. Early documentation of therapeutic response at 6 weeks following corticosteroid therapy in extensive sarcoidosis: promise of FDGPET. Clin Nucl Med. 2009;34:689-690.
    • (2009) Clin Nucl Med. , vol.34 , pp. 689-690
    • Basu, S.1    Asopa, R.V.2    Baghel, N.S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.